Supplementary Figure S9 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
<p>Changes in drug eligibility based on GPSai results. Based on diagnosis & biomarker or diagnosis-only, all cases with added eligibility (a) or ineligibility (b) for the indicated drugs.</p>
Authors
- Jennifer R. Ribeiro (ORCID: https://orcid.org/0000-0002-1685-8568)
- Patricia Pittman
- Anthony Helmstetter
- Hassan Ghani
- Jaclyn F. Hechtman (ORCID: https://orcid.org/0000-0003-2645-0985)
- Rebecca Feldman (ORCID: https://orcid.org/0000-0003-4502-1473)
- Ari M. Vanderwalde (ORCID: https://orcid.org/0000-0002-6842-2563)
- Elena Florento
- Milan M. Radovich (ORCID: https://orcid.org/0000-0001-9667-156X)
- Jeffrey Swensen (ORCID: https://orcid.org/0000-0002-8204-4220)
- Matthew James Oberley (ORCID: https://orcid.org/0000-0001-6419-2513)
- Jim Abraham (ORCID: https://orcid.org/0000-0001-5038-1735)
- Casey Bales (ORCID: https://orcid.org/0000-0002-1016-6042)
- George W. Sledge (ORCID: https://orcid.org/0000-0003-0297-0775)
- Todd Maney
- Farah Abdulla (ORCID: https://orcid.org/0000-0002-3455-7566)
- David B. Spetzler (ORCID: https://orcid.org/0000-0002-9531-0970)
- Myra M. George
- David Bryant
- Stephanie Rock (ORCID: https://orcid.org/0000-0001-5700-6954)
Publication Details
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1158/2767-9764.30021980
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00